Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies - Wikidata - awgldk - TriplyDB

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

http://www.wikidata.org/entity/Q34074602

about

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.Wrist flexion and extension torques measured by highly sensitive dynamometer in healthy subjects from 5 to 80 years.Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation.Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use.Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series.Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity Resistin in idiopathic inflammatory myopathies.Aldolase predicts subsequent myopathy occurrence in systemic sclerosis Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies.Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents.Whole-body MRI for full assessment and characterization of diffuse inflammatory myopathy.The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Disease activity measures in paediatric rheumatic diseases Whole-body MRI in adult inflammatory myopathies: Do we need imaging of the trunk?Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center.Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015 [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis.[Early symptoms of dermatomyositis and antisynthetase syndrome].

P2860

Q27021322-BB6C8C65-AF0D-4B5E-9AD3-D2A84CDEB9B5 Q33670102-212D8D56-5994-4D92-8A0F-B27F6D35A819 Q34644962-CF8187FB-0D58-4F74-AE54-E5948F087D34 Q35067323-A86D07FE-77C2-4FF9-B283-9A9BD1AF477E Q35281980-A741ED99-7D94-43EB-AA0F-81F64200A5D7 Q35755515-356C864D-E1FE-4C52-A360-4440C9224086 Q35824298-EEFFFAF2-F062-4CFD-956F-434C0379523B Q35833312-89F2DE44-D93C-412B-8821-13C188D17425 Q36083205-B856FE5F-5B92-4F37-A755-0599176698E1 Q36245680-7224C7E8-7BFE-41C1-A5E2-D7DED7B097F2 Q36245955-F7549971-42AE-45B1-8942-35FC6628DAA5 Q36246152-CB9844E9-DF72-4DD5-8CE5-EDC2C1F3A781 Q36278027-634DE332-C9F1-46E9-BA35-007A3C7EE07B Q36421845-A8748F4D-72D1-4293-B0B3-630DB6BD68E8 Q36434501-51FD75F4-AEAA-4A48-A9DC-58346DC8B7D1 Q36434543-0945D23D-FE43-4F78-B0B8-6E264C139F62 Q36498667-79D9DF01-4CE0-4FEC-ABDA-468C408E888F Q36532789-97EF9979-4F16-4942-9675-390F9E5F7DD0 Q36559044-DA4E244B-CD65-4246-8E2A-8322049153A8 Q36591665-11FD1C2D-146B-4EB4-8B17-2AECB5EA2330 Q36758692-258F6510-5ABE-453D-9439-63DDCD477D8D Q36994516-A1FC45BC-5BF7-42E0-BF8D-3FBDB2AAFACB Q37278182-983FEA30-F934-4B47-B2AC-A31DDDF277AC Q37293030-29189A7B-C4FC-47AF-97B2-23EEDFB67E42 Q37316551-B14FCF91-8A7E-4574-A84E-AD4A47FB6231 Q37368405-7EFAC464-1E08-4289-9258-89EC2C76EF61 Q37388175-72D0ACC2-3513-44EA-BD02-3A958CE7ED33 Q37604939-5F742F06-8381-4290-829A-24F949638C6E Q37704799-72FAB20F-B88F-418A-8A7D-BAC53A4F68FA Q38148751-6720E1A1-09FE-4EAF-9001-F1793CFB5E17 Q38436563-1C1D67CE-D552-4D08-BD6A-2DE864DF2AD4 Q38589395-76A006DD-73F7-4816-8E75-C464E4DB9C3A Q38619523-08227212-942A-40E0-BAAC-17C3A0BF4802 Q39993595-ECDFB7AF-1F5F-4918-8141-CB55BCBC316E Q40298726-F6AD1E89-3EDF-4ACE-A40B-16D4B75E4F50 Q40711379-1CEBF45B-F439-455C-8CB3-06A71FD985C9 Q40799107-995B5B4A-AC67-46D9-B416-6C4E4DD015B3 Q42365042-50A9370C-B324-43C8-A3F7-89C437879E0F Q44304532-120C08FB-3F03-4362-AB2D-FE033AC46326 Q44920626-D60A9B6C-0CF0-44B8-8DD1-B6EA8EF52CB3

P2860

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

http://www.wikidata.org/entity/Q34074602

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Validation of manual muscle te ...... pathic inflammatory myopathies

@ast

Validation of manual muscle te ...... pathic inflammatory myopathies

@en

Validation of manual muscle te ...... pathic inflammatory myopathies

@nl

type

label

Validation of manual muscle te ...... pathic inflammatory myopathies

@ast

Validation of manual muscle te ...... pathic inflammatory myopathies

@en

Validation of manual muscle te ...... pathic inflammatory myopathies

@nl

prefLabel

Validation of manual muscle te ...... pathic inflammatory myopathies

@ast

Validation of manual muscle te ...... pathic inflammatory myopathies

@en

Validation of manual muscle te ...... pathic inflammatory myopathies

@nl

P1433

Q34074602-91B99F14-1CE6-47C2-A0AA-38CDBE10F7D5

P1476

Q34074602-90EC50BA-FA10-4685-90E4-1201D383F0B9

P2093

Q34074602-23172F80-326C-4659-8C20-F282BBEF799B

Q34074602-3A1E899B-5E0D-4AAC-8726-A3D8B5608AC3

Q34074602-3AEEAF04-1359-46E8-9CCD-B0AE12B420F7

Q34074602-3B24CC9A-DA6C-42E5-9481-34375A9D8B52

Q34074602-5CB85E3F-178F-402A-82FD-0BB4A16EEDDB

Q34074602-784B5ED0-5E17-4452-B800-540F6F270CED

Q34074602-93110339-890A-46EA-99A0-282422D763DA

Q34074602-957EDEC1-C1F9-40C9-A369-482DA1C5A5B8

Q34074602-99C16FDA-7BFE-40BD-AF9A-9EAF795A5D19

Q34074602-AE4384B8-B6A9-4B6E-94A2-B3028352D315

P2860

Q34074602-1CBB4E16-3D80-4470-8072-A51C13B571F6

Q34074602-2257290A-4523-4EDC-AC0F-F49D68E70481

Q34074602-24EFD295-534B-489A-894B-594A31716831

Q34074602-2BAB551C-8FF6-4A48-8D5A-EB067E897165

Q34074602-3C08C2E0-8C2F-4D08-B93D-1E15C3117C90

Q34074602-64C0AF66-8E7B-4EB5-B4E6-D8C29A0E9307

Q34074602-7EF9B4AC-C7CC-4FD5-9309-9AC1C78C3952

Q34074602-981EBD1E-669A-436E-8DD5-8DA9361DAA41

Q34074602-9FD62394-7E3F-4C1A-9B57-89AD2DC6B0E5

Q34074602-C0312CE1-0F8D-4F66-8A34-DE804895BF1C

P304

Q34074602-B845AD68-35A7-4ACB-8976-445CFA71B3CF

P31

Q34074602-3D5FC39B-C012-491C-B3E5-6A6A16582FA2

P356

Q34074602-0144A5A5-53B7-4B06-9EB4-16E5E49F2F46

P433

Q34074602-56C01E97-8358-4F60-9AE7-02BE5A33E3AE

P478

Q34074602-80267556-8D3E-4F82-A585-4BE9061DAD40

P50

Q34074602-122FA3B5-8A00-4BBB-A718-20F24EEC5BD9

Q34074602-80FDDF20-C6FF-4ECD-969A-911FB2B40B01

P577

Q34074602-B00BEF2B-B7F3-4939-8165-3319AE33A2A1

P5875

Q34074602-FD294786-58D7-4FB7-9904-F80655FADF77

P698

Q34074602-AB25CD84-C4F1-4584-B944-4B65034C8BAA

P932

Q34074602-32D94250-3034-43F4-8F73-DFC8A22EF902

P356

P1433

Arthritis Care and Research

P1476

Validation of manual muscle te ...... pathic inflammatory myopathies

@en

P2093

Brian M Feldman

http://www.w3.org/2001/XMLSchema#string

Carol B Lindsley

http://www.w3.org/2001/XMLSchema#string

Daniel J Lovell

http://www.w3.org/2001/XMLSchema#string

Deloris Koziol

http://www.w3.org/2001/XMLSchema#string

Edward H Giannini

http://www.w3.org/2001/XMLSchema#string

Jeanne E Hicks

http://www.w3.org/2001/XMLSchema#string

Kristi Whitney-Mahoney

http://www.w3.org/2001/XMLSchema#string

Lauren M Pachman

http://www.w3.org/2001/XMLSchema#string

Maria L Villalba

http://www.w3.org/2001/XMLSchema#string

Michaele R Smith

http://www.w3.org/2001/XMLSchema#string

P2860

On the reliability and validity of manual muscle testing: a literature review

Polymyositis and dermatomyositis (first of two parts).

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.

Polymyositis and dermatomyositis.

Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.

Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies.

Defining Clinical Improvement in Adult and Juvenile Myositis.

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies.

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis

P304

465-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.20035

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Frederick W. Miller

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43136459

http://www.w3.org/2001/XMLSchema#string

P698

20391500

http://www.w3.org/2001/XMLSchema#string

P932

2924143

http://www.w3.org/2001/XMLSchema#string